Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Pharma
ImmunityBio shares tank despite ph. 3 win in first-line NMIBC
With a phase 3 win in front-line non-muscle invasive bladder cancer, ImmunityBio is heading to the FDA for a label expansion.
Donavyn Coffey
Nov 10, 2026 3:06pm
Summit sheds commercial leaders before ivonescimab FDA decision
Nov 10, 2026 2:12pm
Asking More of Science: How Daiichi Sankyo Is Challenging Assumptions About the Future of Cancer Care
Brought to you by
Daiichi Sankyo, Inc.
J&J's Caplyta scores 2nd ph. 3 win in bipolar mania
Nov 10, 2026 10:01am
Why AI’s Biggest Value in Pharma Is Confidence
Brought to you by
/prompt
WuXi AppTec removed from US list of Chinese military companies
Nov 10, 2026 8:51am
